Form 4: Research Frontiers Inc. Director Acquires Stock Options

Director Darryl Daigle of Research Frontiers Inc. was granted 45,000 stock options, some of which are contingent on shareholder approval.

Summary

• Darryl Daigle, a director at Research Frontiers Inc., has reported a transaction involving the acquisition of stock options.
• The transaction occurred on December 31, 2024.
• Daigle acquired 45,000 stock options with an exercise price of $1.68.
• 27,950 of these options are contingent on shareholder approval at the 2025 Annual Meeting of Stockholders for additional shares under the 2019 Equity Incentive Plan.
• If shareholder approval is not obtained, these contingent options will automatically terminate.
• Following this transaction, Daigle directly owns 327,494 derivative securities.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as it reflects a standard transaction of stock options being granted to a director, which is generally seen as a positive sign of alignment with shareholder interests. However, the contingency on shareholder approval introduces a slight element of uncertainty.

Positives

• The acquisition of stock options by a director can be seen as a positive sign of confidence in the company's future performance.

Risks

• The contingency of 27,950 options on shareholder approval introduces a risk that these options may not be fully granted if the required approval is not obtained.

Future Outlook

The grant of options is contingent on shareholder approval at the 2025 Annual Meeting of Stockholders.

Industry Context

This is a standard transaction for a director of a publicly traded company, often used as part of compensation and incentive programs.

Comparison to Industry Standards

• Stock option grants to directors are a common practice in publicly traded companies, aligning their interests with those of shareholders.
• The specific terms of the options, such as the exercise price and vesting schedule, are typical for such grants.
• The contingency on shareholder approval is a standard measure to ensure proper governance and shareholder oversight.

Stakeholder Impact

• Shareholders may view the stock option grant as a positive sign of management's commitment to the company's success.
• The contingency on shareholder approval ensures that shareholders have a say in the dilution of their ownership.

Next Steps

• Shareholder approval will be sought at the 2025 Annual Meeting of Stockholders for the additional shares required for the contingent options.

Key Dates

Keywords

stock options, director, equity incentive plan, shareholder approval, derivative securities, Research Frontiers Inc., REFR